Literature DB >> 15124670

Targeted therapy of AML new concepts.

M Andreeff1, M Milella, B Z Carter, Y Tabe, M R Ricciardi, T Sneed, P Ruvolo, R Contractor, T Tsao, W Schober, R Evans, T McQueen, Z Zeng, S M Kornblau, J McCubrey, E Estey, G B Mills, J C Reed, M Konopleva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15124670     DOI： 10.1007/s00277-004-0849-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

1.  The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells.

Authors:  Peter P Ruvolo; Vivian R Ruvolo; Rodrigo Jacamo; Jared K Burks; Zhihong Zeng; Seshagiri R Duvvuri; Liran Zhou; Yihua Qiu; Kevin R Coombes; Nianxiang Zhang; Suk Y Yoo; Rongqing Pan; Numsen Hail; Marina Konopleva; George Calin; Steven M Kornblau; Michael Andreeff
Journal:  Biochim Biophys Acta       Date:  2014-05-21

2.  Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment.

Authors:  Zhihong Zeng; Yue Xi Shi; Twee Tsao; YiHua Qiu; Steven M Kornblau; Keith A Baggerly; Wenbin Liu; Katti Jessen; Yi Liu; Hagop Kantarjian; Christian Rommel; David A Fruman; Michael Andreeff; Marina Konopleva
Journal:  Blood       Date:  2012-07-23       Impact factor: 22.113

3.  Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.

Authors:  Peter P Ruvolo; Vivian R Ruvolo; Christopher B Benton; Ahmed AlRawi; Jared K Burks; Wendy Schober; James Rolke; George Tidmarsh; Numsen Hail; R Eric Davis; Michael Andreeff
Journal:  Biochim Biophys Acta       Date:  2015-12-17

4.  Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.

Authors:  Patricia Macanas-Pirard; Richard Broekhuizen; Alfonso González; Claudia Oyanadel; Daniel Ernst; Patricia García; Viviana P Montecinos; Felipe Court; Mauricio Ocqueteau; Pablo Ramirez; Bruno Nervi
Journal:  Oncotarget       Date:  2017-04-04

5.  Down-Regulation of Ribosomal S6 kinase RPS6KA6 in Acute Myeloid Leukemia Patients.

Authors:  Mohammad Rafiee; Mohammad Reza Keramati; Hosein Ayatollahi; Mohammad Hadi Sadeghian; Mohieddin Barzegar; Ali Asgharzadeh; Mohsen Alinejad
Journal:  Cell J       Date:  2016-05-30       Impact factor: 2.479
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.